1. Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD, Carter SG, Damm C, Hines JD (1986) Chemoradiotherapy as initial management in patients with squamous cell carcinoma of the head and neck. Cancer Treat Rep 70: 761–767.
2. Ammon J, Kreidler J, Goronzy J (1979) Ergebnisse einer zytostatischen Kombinationsbehandlung der metastasierten Mamma-und kleinzelligen Bronchialkarzinome unter teilweiser Blockade des Zellzyklus. In: Wannenmacher M (Hrsg) Kombinierte Strahlen-und Chemotherapie. Urban & Schwarzenberg, München.
3. Ammon J, Katsohi D, Karstens JH (1986) Radiotherapie with concurrent a administration of Mitoxantrone in patients with thyroid carcinoma. Cancer Chemother Pharmacol [Suppl] 1, 18 (Abstract Nr.9).
4. Belliveau JF, Posner MR, Ferrari L, Crabtree GW, Cummings FJ, Wiemann MC, O’leary Jr GP, Griffin H, Phaneuf MA, O’Rourke A, Calabresi P (1986) Cisplatin administered as a continuous 5-day infusion: Plasma Platinum Levels and Urine Platinum excretion. Cancer Treat Rep 70: 1215–1217.
5. Coleman CN, Wassermann TH, Urtasun RC, Halsey J, Hirst VK, Hancock S, Phillips TL (1986) Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. Int J Radiat Oncol Biol Phys 12: 1105–1108.